| Serial Number | 79276822 |
| Word Mark | HUB ORGANOID |
| Filing Date | Wednesday, October 23, 2019 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, January 26, 2021 |
| Registration Number | 6253487 |
| Registration Date | Tuesday, January 26, 2021 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, November 10, 2020 |
| Goods and Services | Cells for medical and veterinary, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; cells for medical and veterinary, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; stem cells for medical and veterinary, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; stem cells for medical and veterinary, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; epithelial cells for medical and veterinary, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; epithelial cells for medical and veterinary, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; organoids, namely, self-organized three-dimensional tissue cultures derived from stem cells and cell cultures for medical and veterinary, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; organoids, namely, self-organized three-dimensional tissue cultures derived from stem cells and cell cultures for medical and veterinary, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; cell cultures for medical and veterinary, diagnostic and therapeutic purposes, namely, cells grown in culture media for use in diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; cell cultures for medical and veterinary, diagnostic and therapeutic purposes, namely, cells grown in culture media for use in diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; diagnostic and analytical preparations for medical purposes; biological tissue cultures for medical and veterinary purposes; assays and assay preparations for medical and veterinary diagnostic testing of cells, cultures and organoids for therapeutic purposes; pharmaceutical and veterinary preparations for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; pharmaceutical and veterinary preparations for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; cells, epithelial cells, organoids and cell cultures for personalised medicine, namely, for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; cells, epithelial cells, organoids and cell cultures for personalised medicine, namely, for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx |
| Goods and Services | Cells, stem cells, epithelial cells, all for scientific research purposes; organoids, namely, self-organized three-dimensional tissue cultures derived from stem cells and cell cultures, for scientific and research use; cell culture reagents for scientific and research use; cell culture media for scientific and research use; diagnostic preparations and reagents for use in science; chemicals used in science and industry; assays and assay reagents for scientific purposes; cell culture media for scientific research purposes |
| Goods and Services | Medical services and surgery; medical and surgical diagnostic services; medical services in the nature of cell transplantation services |
| NOT AVAILABLE | "ORGANOID" |
| Goods and Services | Scientific research; genetic testing for scientific research purposes; medical and pharmacological research services; pharmaceutical drug and vaccine development services; development of pharmaceutical preparations and medicines; medical compound, drug and vaccine discovery, development services, and characterization and validation services in the nature of product quality and efficacy testing for medical compounds, drugs and vaccines; candidate drug and vaccine, drug and vaccine testing services, namely, testing of pharmaceuticals; companion diagnostics, namely, the scientific testing and evaluation of drugs and vaccines for individuals or groups of patients to determine the safety and effectiveness of the drug or vaccine for those patients; food safety testing services; testing of compounds and substances to determine toxicity to cells and organoids, namely, self-organized three-dimensional tissue cultures derived from stem cells and cell cultures; scientific research and diagnostic services in the field of personalized medicine |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 27, 2020 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 27, 2020 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 27, 2020 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 27, 2020 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | HUB Organoids IP B.V. |
| Party Type | 32 - New Owner After Registration |
| Legal Entity Type | 78 - NOT AVAILABLE |
| Address | NL |
| Party Name | HUB Organoids B.V. IP |
| Party Type | 31 - New Owner After Registration |
| Legal Entity Type | 99 - Other |
| Address | NL |
| Party Name | Stichting Hubrecht Organoid Technology |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | NL |
| Party Name | Stichting Hubrecht Organoid Technology |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | NL |
| Party Name | Stichting Hubrecht Organoid Technology |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | NL |
| Event Date | Event Description |
| Thursday, January 23, 2020 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Saturday, March 21, 2020 | REFUSAL PROCESSED BY IB |
| Monday, January 27, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, January 28, 2020 | ASSIGNED TO EXAMINER |
| Friday, January 31, 2020 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, February 4, 2020 | NON-FINAL ACTION WRITTEN |
| Wednesday, February 5, 2020 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Wednesday, February 26, 2020 | REFUSAL PROCESSED BY MPU |
| Wednesday, February 26, 2020 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Friday, March 20, 2020 | NEW REPRESENTATIVE AT IB RECEIVED |
| Monday, August 24, 2020 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Monday, August 24, 2020 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, August 25, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, August 24, 2020 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, August 24, 2020 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Monday, August 24, 2020 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Monday, August 24, 2020 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, August 25, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, August 25, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, October 2, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, October 21, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, October 21, 2020 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, October 21, 2020 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Sunday, November 8, 2020 | NOTIFICATION PROCESSED BY IB |
| Tuesday, November 10, 2020 | PUBLISHED FOR OPPOSITION |
| Tuesday, November 10, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, January 26, 2021 | REGISTERED-PRINCIPAL REGISTER |
| Thursday, April 29, 2021 | FINAL DISPOSITION PROCESSED |
| Monday, April 26, 2021 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Sunday, May 23, 2021 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Thursday, April 29, 2021 | FINAL DISPOSITION NOTICE SENT TO IB |
| Friday, April 5, 2024 | CHANGE OF OWNER RECEIVED FROM IB |
| Tuesday, May 7, 2024 | CHANGE OF NAME/ADDRESS REC'D FROM IB |